Page last updated: 2024-08-23

phosphotyrosine and su 11248

phosphotyrosine has been researched along with su 11248 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Abrams, TJ; Cherrington, JM; Lee, LB; Murray, LJ; Pryer, NK1
Coli, R; Deshmukh, GD; Diehl, W; DiNitto, JP; English, JM; Jacques, SL; Worrall, JW; Wu, JC; Zhang, Y1
Dembélé, P; Garnier, O; Martin, DK; Vilgrain, I1

Other Studies

3 other study(ies) available for phosphotyrosine and su 11248

ArticleYear
SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.
    Molecular cancer therapeutics, 2003, Volume: 2, Issue:5

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Carcinoma, Small Cell; Cell Division; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Humans; Imatinib Mesylate; Indoles; Lung Neoplasms; Mice; Mice, Nude; Phosphorylation; Phosphotyrosine; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Stem Cell Factor; Sunitinib; Tumor Cells, Cultured

2003
Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance.
    Journal of biochemistry, 2010, Volume: 147, Issue:4

    Topics: Amino Acid Substitution; Antineoplastic Agents; Benzamides; Catalytic Domain; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Humans; Imatinib Mesylate; Indoles; Kinetics; Microchemistry; Models, Biological; Mutant Proteins; Peptide Mapping; Phosphorylation; Phosphotyrosine; Piperazines; Protein Binding; Protein Interaction Domains and Motifs; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Recombinant Fusion Proteins; Sunitinib

2010
Microtumor Spheroids Provide a Model for Studying Molecules Involved in Vascular Organization: An Illustrative Study for VE-cadherin.
    Anticancer research, 2022, Volume: 42, Issue:10

    Topics: Animals; Antigens, CD; Cadherins; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Sunitinib; Tyrosine

2022